Envestnet Asset Management Inc Novavax Inc Transaction History

Envestnet Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$69.73 - $142.9 $142,040 - $291,087	-2,037 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$134.56 - $217.97 $672 - $1,089	5 Added 0.25%	2,037 $291,000
Q3 2021 Oct 07, 2021	BUY	$177.8 - $270.58 $154,152 - $234,592	867 Added 74.42%	2,032 $421,000
Q2 2021 Aug 04, 2021	SELL	$121.0 - $257.67 $135,520 - $288,590	-1,120 Reduced 49.02%	1,165 $247,000
Q1 2021 May 04, 2021	BUY	$112.98 - $319.93 $258,159 - $731,040	2,285 New	2,285 $414,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.